SEC Form 4 · accession 0001127602-17-023520
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Jul 10, 2017
Accepted (ET)
Jul 12, 2017 · 7:15 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2017 | S | 200 | $99.92 | D | 336,478 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.98 | D | 336,378 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $100.125 | D | 336,278 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $100.13 | D | 336,178 | D | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.